Axcella Health Inc.
AXLA · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $1 | $13 | $13 |
| G&A Expenses | $2 | $3 | $4 | $4 |
| SG&A Expenses | $2 | $3 | $4 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $4 | $4 | $17 | $17 |
| Operating Income | -$4 | -$4 | -$21 | -$17 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | -$2 | -$1 |
| Pre-Tax Income | -$3 | -$4 | -$23 | -$18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$4 | -$24 | -$19 |
| % Margin | – | – | – | – |
| EPS | -1.25 | -0.051 | -0.45 | -0.35 |
| % Growth | -2,341.4% | 88.6% | -28.6% | – |
| EPS Diluted | -1.16 | -0.051 | -0.45 | -0.35 |
| Weighted Avg Shares Out | 3 | 74 | 54 | 53 |
| Weighted Avg Shares Out Dil | 3 | 74 | 54 | 53 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $10 | $0 |
| EBITDA | -$3 | -$4 | -$11 | -$17 |
| % Margin | – | – | – | – |